• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力及相关疾病:病理学与分子发病机制

Myasthenia gravis and related disorders: Pathology and molecular pathogenesis.

作者信息

Ha James C, Richman David P

机构信息

Department of Neurology, University of California, Davis, United States.

出版信息

Biochim Biophys Acta. 2015 Apr;1852(4):651-7. doi: 10.1016/j.bbadis.2014.11.022. Epub 2014 Dec 6.

DOI:10.1016/j.bbadis.2014.11.022
PMID:25486268
Abstract

Disorders affecting the presynaptic, synaptic, and postsynaptic portions of the neuromuscular junction arise from various mechanisms in children and adults, including acquired autoimmune or toxic processes as well as genetic mutations. Disorders include autoimmune myasthenia gravis associated with acetylcholine receptor, muscle specific kinase or Lrp4 antibodies, Lambert-Eaton myasthenic syndrome, nerve terminal hyperexcitability syndromes, Guillain Barré syndrome, botulism, organophosphate poisoning and a number of congenital myasthenic syndromes. This review focuses on the various molecular and pathophysiological mechanisms of these disorders, characterization of which has been crucial to the development of treatment strategies specific for each pathogenic mechanism. In the future, further understanding of the underlying processes may lead to more effective and targeted therapies of these disorders. This article is part of a Special Issue entitled: Neuromuscular Diseases: Pathology and Molecular Pathogenesis.

摘要

影响神经肌肉接头突触前、突触和突触后部分的疾病在儿童和成人中由多种机制引起,包括获得性自身免疫或毒性过程以及基因突变。这些疾病包括与乙酰胆碱受体、肌肉特异性激酶或Lrp4抗体相关的自身免疫性重症肌无力、兰伯特-伊顿肌无力综合征、神经末梢兴奋性过高综合征、格林-巴利综合征、肉毒中毒、有机磷中毒以及一些先天性肌无力综合征。本综述重点关注这些疾病的各种分子和病理生理机制,对其特征的了解对于针对每种致病机制制定治疗策略至关重要。未来,对潜在过程的进一步了解可能会带来对这些疾病更有效、更有针对性的治疗。本文是名为:神经肌肉疾病:病理学与分子发病机制的特刊的一部分。

相似文献

1
Myasthenia gravis and related disorders: Pathology and molecular pathogenesis.重症肌无力及相关疾病:病理学与分子发病机制
Biochim Biophys Acta. 2015 Apr;1852(4):651-7. doi: 10.1016/j.bbadis.2014.11.022. Epub 2014 Dec 6.
2
Myasthenia and related disorders of the neuromuscular junction.神经肌肉接头的重症肌无力和相关疾病。
J Neurol Neurosurg Psychiatry. 2010 Aug;81(8):850-7. doi: 10.1136/jnnp.2008.169367. Epub 2010 Jun 14.
3
Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.自身免疫性肌无力综合征的发病机制与临床关联
Semin Neurol. 2018 Jun;38(3):344-354. doi: 10.1055/s-0038-1660500. Epub 2018 Jul 16.
4
Autoimmune disorders of neuromuscular transmission.神经肌肉传递的自身免疫性疾病
Semin Neurol. 2008 Apr;28(2):212-27. doi: 10.1055/s-2008-1062260.
5
[Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].[神经肌肉传递障碍的免疫学方面。2. 实验性自身免疫性重症肌无力和兰伯特-伊顿肌无力综合征]
Lijec Vjesn. 1994 May-Jun;116(5-6):158-61.
6
Clinical aspects of myasthenia explained.解释重症肌无力的临床方面。
Autoimmunity. 2010 Aug;43(5-6):344-52. doi: 10.3109/08916931003602130.
7
[Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].[在乙酰胆碱受体抗体阴性重症肌无力中检测到的自身抗体]
Rinsho Byori. 2014 Mar;62(3):255-60.
8
Autoimmune mediated neuromuscular junction defects.自身免疫介导的神经肌肉接头缺陷。
Curr Opin Neurol. 2010 Oct;23(5):489-95. doi: 10.1097/WCO.0b013e32833cc968.
9
Myasthenia gravis and the neuromuscular junction.重症肌无力与神经肌肉接头
Curr Opin Neurol. 2013 Oct;26(5):459-65. doi: 10.1097/WCO.0b013e328364c079.
10
Autoimmune syndromes at the neuromuscular junction.神经肌肉接头处的自身免疫综合征。
J Child Neurol. 1999 Jan;14(1):41-3.

引用本文的文献

1
Long-Term Efficacy and Safety of Ravulizumab in Adults With Anti-Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: Final Results From the Phase 3 CHAMPION MG Open-Label Extension.ravulizumab治疗抗乙酰胆碱受体抗体阳性全身型重症肌无力成人患者的长期疗效和安全性:3期CHAMPION MG开放标签扩展研究的最终结果
Eur J Neurol. 2025 Apr;32(4):e70158. doi: 10.1111/ene.70158.
2
Two-decade battle with myasthenia gravis: A breakthrough case report on the long-term success with eculizumab and ravulizumab treatment.与重症肌无力长达二十年的抗争:关于依库珠单抗和ravulizumab治疗长期成功的突破性病例报告
Clin Case Rep. 2024 Nov 4;12(11):e9547. doi: 10.1002/ccr3.9547. eCollection 2024 Nov.
3
Time to response with ravulizumab, a long-acting terminal complement inhibitor, in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.
抗乙酰胆碱受体抗体阳性全身型重症肌无力成人患者使用长效末端补体抑制剂瑞昔珠单抗的反应时间。
Eur J Neurol. 2024 Dec;31(12):e16490. doi: 10.1111/ene.16490. Epub 2024 Oct 7.
4
Comparative Analysis of Serum Amino Acid Profiles in Patients with Myasthenia Gravis and Multiple Sclerosis.重症肌无力和多发性硬化症患者血清氨基酸谱的比较分析
J Clin Med. 2024 Jul 12;13(14):4083. doi: 10.3390/jcm13144083.
5
The Application Potential of the Regulation of Tregs Function by Irisin in the Prevention and Treatment of Immune-Related Diseases.鸢尾素调控调节性 T 细胞功能在防治免疫相关性疾病中的应用潜力。
Drug Des Devel Ther. 2024 Jul 16;18:3005-3023. doi: 10.2147/DDDT.S465713. eCollection 2024.
6
Ravulizumab in Myasthenia Gravis: A Review of the Current Evidence.瑞武利珠单抗治疗重症肌无力:当前证据综述
Neuropsychiatr Dis Treat. 2023 Dec 1;19:2639-2655. doi: 10.2147/NDT.S374694. eCollection 2023.
7
Sterol derivative binding to the orthosteric site causes conformational changes in an invertebrate Cys-loop receptor.甾醇衍生物与正位点结合导致无脊椎动物 Cys 环受体构象发生变化。
Elife. 2023 Jul 3;12:e86029. doi: 10.7554/eLife.86029.
8
Long-term efficacy and safety of ravulizumab in adults with anti-acetylcholine receptor antibody-positive generalized myasthenia gravis: results from the phase 3 CHAMPION MG open-label extension.抗乙酰胆碱受体抗体阳性全身型重症肌无力成人患者使用拉那利尤单抗的长期疗效和安全性:III 期 CHAMPION MG 开放标签扩展研究结果。
J Neurol. 2023 Aug;270(8):3862-3875. doi: 10.1007/s00415-023-11699-x. Epub 2023 Apr 27.
9
Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis.瑞夫利珠单抗在全身型重症肌无力患者中的药代动力学和药效学。
J Neurol. 2023 Jun;270(6):3129-3137. doi: 10.1007/s00415-023-11617-1. Epub 2023 Mar 9.
10
Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan.日本兰伯特-伊顿肌无力综合征的全国性调查。
BMJ Neurol Open. 2022 Sep 5;4(2):e000291. doi: 10.1136/bmjno-2022-000291. eCollection 2022.